| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8734232 | Pediatric Hematology Oncology Journal | 2018 | 4 Pages |
Abstract
Patients with standard risk hepatoblastoma have survival outcomes comparable to Western countries, however, outcomes in patients with high risk non-metastatic inoperable disease remains low due to financial constraints in performing liver transplantation. Multimodality treatment including NACT with PLADO based regimens followed by resection is a feasible strategy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Avaronnan Manuprasad, Venkatraman Radhakrishnan, Sunil B. J, A.S. Ramakrishnan, T.S. Ganesan, Prasanth Ganesan, Jaikumar Ramamurthy, Manikandan Dhanushkodi, T.G. Sagar,